Halozyme Therapeutics, Inc.

Vanguard Personalized Indexing Management, LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

30,669

Value ($000)

2,064

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,064	0.0%	30,669	12/31/2025
2025 Q3	10/31/2025	2,299	0.0%	31,344	9/30/2025
2025 Q2	7/25/2025	1,541	0.0%	29,629	6/30/2025
2025 Q1	5/14/2025	1,462	0.0%	22,912	3/31/2025
2024 Q4	2/10/2025	1,028	0.0%	21,492	12/31/2024
2024 Q3	11/12/2024	1,195	0.0%	20,875	9/30/2024
2024 Q2	8/12/2024	1,084	0.0%	20,711	6/30/2024
2024 Q1	5/9/2024	742	0.0%	18,248	3/31/2024
2023 Q4	2/8/2024	741	0.0%	20,050	12/31/2023
2023 Q3	11/8/2023	412	0.0%	10,778	9/30/2023
2023 Q2	7/28/2023	364	0.0%	10,090	6/30/2023
2023 Q1	5/10/2023	511	0.0%	13,368	3/31/2023
2022 Q4	2/10/2023	811	0.0%	14,258	12/31/2022
2022 Q3	11/14/2022	499	0.0%	12,618	9/30/2022
2022 Q2	8/12/2022	246	0.0%	5,582	6/30/2022